C反应蛋白/白蛋白比值对接受涉及喉切除术的侵入性手术的下咽癌和喉癌患者的预后价值
本研究回顾性分析2003至2012年间接受全喉切除术或全咽喉切除术的56例下咽癌和喉癌患者,评估C反应蛋白/白蛋白(CRP/Alb)比值的预后价值。CRP/Alb比值的最佳截断值为0.32,多因素分析显示其为总生存和无病生存不良的显著独立预测因素。作者认为CRP/Alb比值可能是一种预测术后结局的新颖有用指标。
要点
- CRP/Alb比值最佳截断值为0.32。
- 多因素分析显示CRP/Alb比值为总生存不良的显著独立预测因素。
- 多因素分析显示CRP/Alb比值为无病生存不良的显著独立预测因素。
核心结论
- CRP/Alb比值可能是一种预测下咽癌和喉癌患者术后结局的新颖有用指标。
研究设计与样本
- 回顾性评估2003至2012年间接受全喉切除术或全咽喉切除术的56例下咽癌和喉癌患者。
- 采用单因素和多因素分析检验CRP/Alb比值的预后价值。
主要发现
- CRP/Alb比值的最佳截断值为0.32。
- 多因素分析显示CRP/Alb比值为总生存不良的显著独立预测因素。
- 多因素分析显示CRP/Alb比值为无病生存不良的显著独立预测因素。
关键数值与推荐
- CRP/Alb比值最佳截断值为0.32。
- 多因素分析显示CRP/Alb比值为总生存和无病生存不良的显著独立预测因素。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The C-reactive protein/albumin (CRP/Alb) ratio has been recently established as a prognostic indicator in various cancer types. However, few reports regarding the prognostic value of the CRP/Alb ratio in head and neck cancer exist. This study aimed to investigate the significance of the CRP/Alb ratio in clinical outcomes after invasive surgery involving laryngectomy for hypopharyngeal and laryngeal cancer. METHODS: We evaluated 56 patients who underwent total laryngectomy or total pharyngolaryngectomy between 2003 and 2012. Univariate and multivariate analyses were retrospectively performed to examine the prognostic value of the CRP/Alb ratio in these patients. RESULTS: The optimal cutoff value of the CRP/Alb ratio was 0.32. Multivariate analysis showed that the CRP/Alb ratio was a significant and independent predictor of poor overall and disease-free survival. CONCLUSION: The CRP/Alb ratio may be a novel and useful indicator for predicting postoperative outcomes in patients with hypopharyngeal and laryngeal cancer.
引用
- Kuboki A, Kanaya H, Nakayama T, et al. Prognostic value of C-reactive protein/albumin ratio for patients with hypopharyngeal and laryngeal cancer undergoing invasive surgery involving laryngectomy. Head Neck. 2018. PMID: 30552844. doi:10.1002/hed.25565
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。